Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
22-Dec-2025 | 435 | 446.95 | 431.55 | 443.15 | 10,824 | 13,69,67,419.6 | 89,050 |
23-Dec-2025 | 458 | 480.5 | 446.1 | 452.15 | 70,569 | 1,84,57,51,766.15 | 5,41,034 |
24-Dec-2025 | 447.1 | 453.2 | 444.95 | 446.3 | 5,955 | 8,02,56,703 | 78,107 |
26-Dec-2025 | 449.9 | 450 | 442.05 | 446.4 | 4,054 | 5,12,64,116.05 | 51,985 |
29-Dec-2025 | 450 | 450.3 | 444.05 | 447.15 | 3,984 | 6,00,09,295.4 | 58,653 |
30-Dec-2025 | 449.75 | 453 | 442.85 | 450.85 | 5,391 | 6,79,65,547.25 | 69,951 |
31-Dec-2025 | 452.25 | 461.95 | 449.6 | 453.4 | 5,089 | 6,97,79,173.1 | 77,405 |
01-Jan-2026 | 453.4 | 453.7 | 445.05 | 445.9 | 1,760 | 2,47,87,630.7 | 24,872 |
02-Jan-2026 | 445.9 | 455.6 | 445.15 | 451.85 | 3,061 | 3,88,74,618.15 | 39,720 |
05-Jan-2026 | 451.05 | 455.1 | 444 | 447.35 | 2,963 | 2,95,17,731.9 | 33,758 |
06-Jan-2026 | 452 | 452 | 441.15 | 444.8 | 2,720 | 2,83,07,578 | 33,053 |
07-Jan-2026 | 446.9 | 456 | 445.1 | 454.75 | 4,143 | 4,66,51,923.75 | 62,438 |
08-Jan-2026 | 455 | 458 | 445.05 | 446.8 | 3,435 | 4,25,63,263.8 | 48,730 |
09-Jan-2026 | 447.85 | 447.85 | 437.55 | 444.8 | 2,816 | 4,40,21,766.75 | 61,417 |
12-Jan-2026 | 447.45 | 447.45 | 434.4 | 444.3 | 4,009 | 4,26,29,466.15 | 42,817 |
13-Jan-2026 | 442.05 | 447.3 | 439.9 | 443.85 | 1,966 | 1,97,63,205 | 22,059 |
14-Jan-2026 | 444 | 448.65 | 440.75 | 444.45 | 2,310 | 4,12,90,439.45 | 57,070 |
16-Jan-2026 | 443.8 | 445.7 | 440.5 | 444.1 | 1,609 | 2,67,49,166.35 | 35,795 |
19-Jan-2026 | 443.45 | 445.8 | 437 | 437.35 | 4,974 | 4,22,71,727.4 | 43,824 |
20-Jan-2026 | 439 | 441 | 420.1 | 421.45 | 5,960 | 4,42,04,502.6 | 56,561 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
